<DOC>
	<DOCNO>NCT02557087</DOCNO>
	<brief_summary>The aim study ass whether hyoscine butylbromide effective pethidine analgesia first stage labor .</brief_summary>
	<brief_title>Hyoscine ButylBromide Intrapartum Analgesia</brief_title>
	<detailed_description />
	<mesh_term>Scopolamine Hydrobromide</mesh_term>
	<mesh_term>Meperidine</mesh_term>
	<mesh_term>Butylscopolammonium Bromide</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Primiparity Active phase labor ( cervical dilatation 35 cm , presence adequate uterine contraction ; last least 40 second interval 34 minute ) Maternal age 2030 year Singleton term pregnancy ( 3742 week gestation ) Vertexpresenting fetus Clinical evidence cephalopelvic disproportion . Scarred uterus ; previous cesarean section , hysterotomy myomectomy . Any medical disorder associate pregnancy . Fetal distress Receiving regional parenteral analgesia recruitment study Known hypersensitivity drug family</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>